๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX ยท Real-Time Price ยท USD
8.89
+0.34 (3.98%)
Nov 18, 2026, 4:00 PM EST - Market closed

Turn Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Profit
-2.25-0.5---
Operating Income
-9.27-6.36-1.8-2.31-4.21
Net Income
-12.77-3.19-1.77-2.29-4.29
Earnings Per Share
-0.43-0.12-0.07-0.09-
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
10.365.080.871.182.1
Total Debt
6.230.080.120.030.08
Net Cash (Debt)
4.1350.751.162.02
Net Cash Growth
37.07%564.72%-34.98%-42.76%-
Net Cash Per Share
0.140.180.030.04-

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-5.28-2.56-1.36-1.38-1.21
Free Cash Flow
-5.28-2.56-1.36-1.38-1.21
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.